Revenue was 26,893 million yen, up 18.5% year-over-year; operating income was 3,990 million yen, up 46.4% year-over-year. At 2Q gross profit margin improved from 40.1% to 42.6%. Full-year outlook was revised upward to revenue of 54,175 million yen and operating income of 7,537 million yen. Despite foreign exchange impacts, strong segment performance drove a substantial increase in interim net income.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6237","jir_company_name":"Iwaki Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/6237-20261113-02.pdf","jir_short_summary":"Revenue was 26,893 million yen, up 18.5% year-over-year; operating income was 3,990 million yen, up 46.4% year-over-year. At 2Q gross profit margin improved from 40.1% to 42.6%. Full-year outlook was revised upward to revenue of 54,175 million yen and operating income of 7,537 million yen. Despite foreign exchange impacts, strong segment performance drove a substantial increase in interim net income.","jir_summary":"### Overview of Performance\nIn the 2nd quarter of this fiscal year, revenue grew substantially year-on-year driven by strong performance in the domestic medical device market and the U.S. water treatment market, as well as demand from Asia's semiconductor and LCD markets. Inventory optimization reduced cost of goods sold ratio, and despite a slight increase in SG&A ratio, operating margin reached a record high since listing. By segment, strength in semiconductor & LCD, medical devices, and surface treatment equipment contributed. Equity-method investment income also supported results, lifting profit at each stage including ordinary income, and interim net income attributable to owners of the parent increased significantly by 47.5% year-on-year.\n\n### Outlook and Financial Targets\nFor the fiscal year ending March 2027, the company expects revenue growth in the second half assuming continued strength in the semiconductor & LCD, medical device, and surface treatment equipment markets, and anticipates improvement in operating margin. The financial targets of the Medium-Term Management Plan 2027 are expected to be largely achieved. Some foreign exchange sensitivity is assumed to have an impact in the second half.","jir_financial_highlights":"Revenue: 26,893 (YoY +18.5%)\nGross Profit: 11,454 (YoY +25.7%)\nOperating Income: 3,990 (YoY +46.4%)\nNet Income Attributable to Owners of Parent (interim): 3,392 (YoY +47.5%)\nInterim Net Income per Share: 152.85 yen (YoY +47.2%)","jir_category":"","jir_hashtags":"#ConsideringShareBuyback, #EarningsPresentationReleased, #MediumTermPlan, #CurrencyImpact","jir_key_figures":"Revenue: 26,893 million yen (YoY +18.5%)\nOperating Income: 3,990 million yen (YoY +46.4%)\nNet Income Attributable to Owners of Parent (interim): 3,392 million yen (YoY +47.5%)","jir_meta_title":"Iwaki Co., Ltd. \u2013 FY2027 2Q Earnings Summary | Revenue 26,893 million yen, +18.5% YoY","jir_meta_description":"Key points of Iwaki Co., Ltd.'s FY2027 2nd quarter earnings: revenue +18.5% YoY, operating income +46.4% YoY, and a significant rise in interim net income. Full-year outlook: revenue 54,175 million yen, operating income 7,537 million yen.","jir_og_title":"Iwaki Co., Ltd. | FY2027 2Q Earnings Summary","jir_og_description":"Iwaki Co., Ltd.'s 2nd quarter results: revenue 26,893 million yen and operating income 3,990 million yen, showing substantial growth. Full-year forecast: revenue 54,175 million yen and operating income 7,537 million yen. See IR materials for details.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"2025.3Q\\\",\\\"2026.3Q\\\",\\\"2027.3Q\\\"],\\\"datasets\\\":[{\\\"data\\\":[11220,11219,11966],\\\"label\\\":\\\"Revenue\\\"}]}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"2025.3Q\\\",\\\"2026.3Q\\\",\\\"2027.3Q\\\"],\\\"datasets\\\":[{\\\"data\\\":[1431,1340,1940],\\\"label\\\":\\\"Operating Income\\\"}]}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Revenue by Market\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"Water Treatment\\\",\\\"Semiconductor & LCD\\\",\\\"Medical Devices\\\",\\\"Chemicals\\\",\\\"Surface Treatment Equipment\\\",\\\"New Energy\\\",\\\"Other\\\"],\\\"datasets\\\":[{\\\"data\\\":[1260,4509,5569,5497,2974,777,10872]}]}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Gross Profit Margin & SG&A Ratio Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"FY2025\\\",\\\"FY2026\\\",\\\"FY2027\\\"],\\\"datasets\\\":[{\\\"data\\\":[41.1,40.7,40.1],\\\"label\\\":\\\"Gross Profit Margin\\\"},{\\\"data\\\":[28.4,28.9,27.3],\\\"label\\\":\\\"SG&A Ratio\\\"}]}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Guidance vs. Actual Comparison\", \"jir_chart_json_data\": \"{\\\"labels\\\":[\\\"FY2026 2Q\\\",\\\"FY2027 2Q\\\"],\\\"datasets\\\":[{\\\"data\\\":[0,0],\\\"label\\\":\\\"Forecast vs Actual Gap\\\"}]}\"}]","ir_related_company":17230,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-153170","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n